Inside Precision Medicine December 10, 2024
Malorye Branca

We know that cancer deaths are going down dramatically, in part because of better screening and new drugs, but can we get a closer look on how that is happening? A large, multi-institutional team led by researchers at the National Cancer Institute (NCI) looked at that question for several leading cancers: Colorectal, lung, breast, cervical, and prostate cancer from 1975–2020. They found an estimated 5.94 million deaths were averted from these five cancers combined.

The study was published last week in JAMA Oncology. The lead author was Katrina Goddard, director of NCI’s Division of Cancer Control and Population Sciences. It was released on the heels of another study which showed a 62% reduction in cervical cancer in young women, after...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Patient / Consumer, Provider, Survey / Study, Trends
Related Articles:
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Google Care Studio: Improving Patient Outcomes
Amazon One Medical: the beginning of a text-based TeleHealth revolution?
Congressional spending plan: What’s in it for healthcare, and what isn’t
AI’s cognitive gap: Why human doctors remain irreplaceable

Share This Article